CN109180970A - A kind of citric acid cross-linked chitosan and the hydrogel of dopamine and preparation method thereof - Google Patents
A kind of citric acid cross-linked chitosan and the hydrogel of dopamine and preparation method thereof Download PDFInfo
- Publication number
- CN109180970A CN109180970A CN201811005540.3A CN201811005540A CN109180970A CN 109180970 A CN109180970 A CN 109180970A CN 201811005540 A CN201811005540 A CN 201811005540A CN 109180970 A CN109180970 A CN 109180970A
- Authority
- CN
- China
- Prior art keywords
- citric acid
- dopamine
- hydrogel
- chitosan
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
- C08J2305/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
The present invention relates to a kind of citric acid cross-linked chitosan and hydrogels of dopamine and preparation method thereof, the following steps are included: S1 is dissolved chitosan in acetic acid solution, at a certain temperature, dopamine is added and stirs to get blend solution, then citric acid is added, stirring is uniformly mixed it;Solution is placed under low temperature environment by S2, makes its fast cooling, and catalyst progress amidation cross-linking reaction is then added and obtains hydrogel;It is neutral that S3, which washs the gel after crosslinking to pH,.Beneficial effects of the present invention: 1, the present invention utilizes citric acid cross-linked chitosan and dopamine, the hydrogel of non-toxic degradable good using one kettle way biocompatibility;2, the hydrogel that the present invention is formed has ideal pore structure and mechanical property, provides good mentality of designing for the application of chitosan-based hydrogel.
Description
Technical field
The invention belongs to hydrogel preparation field, in particular to a kind of hydrogel of citric acid cross-linked chitosan and dopamine
And preparation method thereof.
Background technique
Chitosan is unique a kind of alkaline polysaccharide in nature, has good biocompatibility, nontoxic, biodegradable, extensively
The general wound tissue that is applied to repairs, skin repair and neural restoration, medicine controlled release carrier, and achieves well in these fields
Effect can be prepared as hydrogel as bio-medical material as organizational project and hydrogel scaffold is provided.
Dopamine is a kind of neurotransmitter, monomer also known as 4- (2- ethylamino-) benzene -1,2- diphenol, while having catechol official
It can roll into a ball and amino, dopamine can be improved the biocompatibility and cell adhesion of material, reduce inflammatory reaction, weaken blood
Immune response, is widely used it as biomaterial.
Citric acid is a kind of ternary acid, has good regulating and controlling effect to cellular energy metabolism in vivo, is had anti-
Oxidation and anti-inflammatory ability, while being also a kind of crosslinking agent of biological nontoxic, utilize the carboxyl and chitosan and DOPA of citric acid
The amino of amine forms hydrogel using one kettle way, and the hydrogel of formation has ideal pore structure and mechanical property.
Hydrogel is a kind of hydrogel object that highly cross-linked hydrophilic polymeric not soluble in water has, and hydrogel has Gao Shuihan
Amount, the porous structure of hydrogel is conducive to inside and outside tissue fluid and swaps, while can provide for cell adherence and growing into
Bracket.Hydrogel is a type soft-tissue material, is commonly used for the material of skin injury reparation, spinal cord injury reparation, is had very big
Function and effect and application prospect, aquagel is applied to spinal cord injury existing research at present, but not can solve spinal cord
Secondary inflammatory problems after damage, and the introducing of citrate and dopamine can effectively mitigate secondary inflammation after spinal cord injury
Reaction, provides good microenvironment for affected area, further promotes the reparation of spinal cord injury.
Summary of the invention
The present invention relates to a kind of citric acid cross-linked chitosan and hydrogel of dopamine and preparation method thereof, can be quick
To a kind of good hydrogel of biocompatibility, with ideal pore structure and mechanical property, and there is anti-oxidant energy
Power can inhibit to can reduce the inflammatory reaction of secondary damage after spinal cord injury while cicatrization for spinal cord injury.
The technical proposal adopted by the invention to solve the above technical problems is that: a kind of citric acid cross-linked chitosan and dopamine
Hydrogel preparation method, which comprises the following steps:
S1 is dissolved chitosan in acetic acid solution, at a certain temperature, dopamine is added and stirs to get blend solution, so
After be added citric acid, stirring is uniformly mixed it;
Solution is placed under low temperature environment by S2, makes its fast cooling, and catalyst is then added and carries out amidation cross-linking reaction
Obtain hydrogel;
It is neutral that S3, which washs the gel after crosslinking to pH,.
According to the above scheme, temperature is 40~70 DEG C in step S1;Mixing time is 0.5~3 hour.
According to the above scheme, acetic acid solution volume fraction is 1%~2% in step S1, and chitosan additive amount is acetic acid solution
3wt%~4wt%.
According to the above scheme, citric acid in step S1, chitosan mass ratio be 1:6~12.
According to the above scheme, the molar ratio of citric acid and dopamine is 1:0~3 in step S1.
According to the above scheme, catalyst be added is 1- (3- dimethylamino-propyl) -3- ethyl carbodiimide/N- in step S2
One of n-hydroxysuccinimide (EDC/NHS), Geniposide and glutaraldehyde.
According to the above scheme, reaction temperature is 4 DEG C~25 DEG C in step S2.
According to the above scheme, it is water, ethyl alcohol or alkaline solution that agents useful for same is washed in step S3.
A kind of hydrogel of citric acid cross-linked chitosan and dopamine, it is characterised in that: apply any of the above-described preparation side
Method is made.
Reaction mechanism of the present invention: this reaction prepares hydrogel using one kettle way, and reaction principle is citric acid as a kind of
Crosslinking agent has amino group on chitosan and dopamine, amide occurs under the effect of the catalyst containing there are three carboxylic group
Reaction, finally obtains hydrogel.
Beneficial effects of the present invention:
1, the present invention utilizes citric acid cross-linked chitosan and dopamine, good using one kettle way biocompatibility, nontoxic
Degradable hydrogel;
2, the hydrogel that the present invention is formed has ideal pore structure and mechanical property, is the application of chitosan-based hydrogel
Provide good mentality of designing.
Detailed description of the invention
Fig. 1 is the citric acid cross-linked chitosan of the embodiment of the present invention 1 and the infrared spectrogram of dopamine hydrogel;
Fig. 2 is the citric acid cross-linked chitosan of the embodiment of the present invention 1 and the ultraviolet spectrogram of dopamine hydrogel;
The citric acid cross-linked chitosan and the scanning electricity after the freeze-drying of dopamine hydrogel that Fig. 3 is the embodiment of the present invention 7
Mirror figure;
Fig. 4 is the citric acid cross-linked chitosan of the embodiment of the present invention 8 and the compression performance test chart of dopamine;
Fig. 5 is hydrogel of the invention to DPPH radicals scavenging lab diagram.
Specific embodiment
Below by specific implementation, invention is further explained, and however, the present invention is not limited to these examples.With
Unless specific instructions, the reagent of use is the pure chemical reagent of commercially available chemistry to lower embodiment.
Embodiment 1
1.2g chitosan is dissolved in 1% acetic acid solution of 40ml and obtains the chitosan solution of 3wt%, under magnetic stirring
Dissolution, is warming up to 40 DEG C, and 0.1806g dopamine is added and stirs 0.5h, is added 0.2g citric acid, in acquired solution, chitosan and
The ratio of citric acid is 6/1, and the molar ratio of citric acid and dopamine is 1/1, completely and after mixing to its dissolution, rapidly
Temperature is reduced to 4, DEG C addition EDC/NHS is poured into mold, is carried out catalysis amide cross-linking reaction and is obtained citric acid cross-linked chitosan
It with the hydrogel of dopamine, is washed in NaOH solution, ethyl alcohol and deionized water three times respectively, obtains final hydrogel, pH
For neutrality.
Infrared spectrogram as shown in Figure 1, in 1640cm-1Place and 1570cm-1The stretching vibration for corresponding to-CO-NH- is inhaled
Peak is received, shows that amide reaction occurs after being added to citric acid, generates amide group, and the ultraviolet spectrogram of Fig. 2 is and independent
Chitosan compare, there is apparent dopamine characteristic peak at 280nm in the hydrogel of synthesis, shows that dopamine is grafted to water
On gel.
Embodiment 2
1.2g chitosan is dissolved in 1% acetic acid solution of 30ml and obtains the chitosan solution of 3wt%, under magnetic stirring
Dissolution, is warming up to 40 DEG C, and 0.3612g dopamine is added and stirs 0.5h, is added 0.2g citric acid, in acquired solution, chitosan and
The ratio of citric acid is 6/1, and the molar ratio of citric acid and dopamine is 1/2, completely and after mixing to its dissolution, rapidly
Temperature is reduced to 4, DEG C addition EDC/NHS is poured into mold, is carried out catalysis amide cross-linking reaction and is obtained citric acid cross-linked chitosan
It with the hydrogel of dopamine, is washed in NaOH solution, ethyl alcohol and deionized water three times respectively, obtains final pH as neutral water-setting
Glue.
Embodiment 3
1.2g chitosan is dissolved in 1% acetic acid solution of 30ml and obtains the chitosan solution of 3wt%, under magnetic stirring
Dissolution is warming up to 40 DEG C, and 0.5418g dopamine is added and stirs 0.5h, 0.2g citric acid, acquired solution chitosan and lemon is added
The ratio of acid is 6/1, and the molar ratio of citric acid and dopamine is 1/3, completely and after mixing to its dissolution, is reduced rapidly
DEG C EDC/NHS is added to 4 in temperature, pours into mold, carries out catalysis amide cross-linking reaction and obtains citric acid cross-linked chitosan and more
The hydrogel of bar amine, is washed three times in NaOH solution, ethyl alcohol and deionized water respectively, obtains final pH as neutral hydrogel.
Embodiment 4
1.2g chitosan is dissolved in 2% acetic acid solution of 40ml and obtains the chitosan solution of 3wt%, under magnetic stirring
Dissolution, is warming up to 70 DEG C, and 0.0903g dopamine is added and stirs 0.5h, is added 0.1g citric acid, in acquired solution, chitosan and
The ratio of citric acid is 12/1, and the molar ratio of citric acid and dopamine is 1/1, completely and after mixing to its dissolution,
Glutaraldehyde is added under room temperature, pours into mold, carries out catalytic crosslinking and reacts to obtain the water of citric acid cross-linked chitosan and dopamine
Gel washs three times in NaOH solution, ethyl alcohol and deionized water respectively, obtains final pH as neutral hydrogel.
Embodiment 5
1.2g chitosan is dissolved in 1.5% acetic acid solution of 30ml and obtains the chitosan solution of 4wt%, in magnetic agitation
Lower dissolution, is warming up to 60 DEG C, is added 0.2g citric acid, and in acquired solution, the ratio of chitosan and citric acid is 6/1, citric acid
It is 1/0 with the molar ratio of dopamine, completely and after mixing to its dissolution, reduces rapidly temperature to 4, DEG C EDC/ is added
NHS is poured into mold, is carried out catalysis amide cross-linking reaction and is obtained the hydrogel of citric acid cross-linked chitosan and dopamine, respectively
It is washed in PBS solution, ethyl alcohol and deionized water three times, obtains final pH as neutral hydrogel.
Embodiment 6
1.2g chitosan is dissolved in 1% acetic acid solution of 40ml and obtains the chitosan solution of 3wt%, under magnetic stirring
Dissolution, is warming up to 40 DEG C, and 0.5418g dopamine is added and stirs 0.5h, is added 0.2g citric acid, in acquired solution, chitosan and
The ratio of citric acid is 6/1, and the molar ratio of citric acid and dopamine is 1/3, completely and after mixing to its dissolution, rapidly
Temperature is reduced to 25 DEG C, Geniposide is added, pours into mold, catalysis amide cross-linking reaction is carried out and obtains citric acid cross-linked chitosan
It with the hydrogel of dopamine, is washed in KOH solution, ethyl alcohol and deionized water three times respectively, obtains final pH as neutral water-setting
Glue.
Embodiment 7
1.2g chitosan is dissolved in 2% acetic acid solution of 30ml and obtains the chitosan solution of 4wt%, under magnetic stirring
Dissolution, is warming up to 70 DEG C, and 0.2709g dopamine is added and stirs 0.5h, is added 0.1g citric acid, in acquired solution, chitosan and
The ratio of citric acid is 12/1, and the molar ratio of citric acid and dopamine is 1/3, completely and after mixing to its dissolution, fast
Prompt drop low temperature is added EDC/NHS, pours into mold to 4 DEG C, and carrying out catalysis amide cross-linking reaction, to obtain citric acid crosslinking shell poly-
The hydrogel of sugar and dopamine, is washed three times in KOH solution, ethyl alcohol and deionized water respectively, and obtaining final pH is neutral water
Gel.
As shown in figure 3, gained hydrogel is freeze-dried, electron-microscope scanning is then shot, as can be seen from the figure water
Gel has good pore structure.
Embodiment 8
1.2g chitosan is dissolved in 1% acetic acid solution of 30ml and obtains the chitosan solution of 4wt%, under magnetic stirring
Dissolution, is warming up to 60 DEG C, and 0.2709g dopamine is added and stirs 0.5h, is added 0.15g citric acid, in acquired solution, chitosan and
The ratio of citric acid is 6/1, and the molar ratio of citric acid and dopamine is 1/2, completely and after mixing to its dissolution, rapidly
Temperature is reduced to 4, DEG C addition EDC/NHS is poured into mold, is carried out catalysis amide cross-linking reaction and is obtained citric acid cross-linked chitosan
It with the hydrogel of dopamine, is washed in KOH solution, ethyl alcohol and deionized water three times respectively, obtains final pH as neutral water-setting
Glue.
As shown in figure 4, be the compression performance test chart of hydrogel, it can as seen from the figure, hydrogel has good anti-
Press performance.
As shown in figure 5, be removing lab diagram of the hydrogel containing different content dopamine to DPPH free radical, wherein CS
Group is individual aquagel group, and CS-CA-DA1, CS-CA-DA2, CS-CA-DA3 is respectively 1,2 He of the embodiment of the present invention
Hydrogel prepared by 3, it can be seen that with the addition of dopamine, the removing ratio of free radical is increased, this shows material
Inoxidizability can increase.
The invention discloses citric acid cross-linked chitosan and dopamine hydrogel and preparation method thereof, this field the relevant technologies
Personnel can use for reference present disclosure, and the appropriate links such as material and route that change are realized, material of the invention and method only introductory section
Important experiment and part exemplary embodiments illustrate the contents of the present invention, but these examples are not intended to limit protection scope of the present invention.
Claims (9)
1. a kind of preparation method of the hydrogel of citric acid cross-linked chitosan and dopamine, which comprises the following steps:
S1 is dissolved chitosan in acetic acid solution, at a certain temperature, be added dopamine stir to get blend solution, then plus
Enter citric acid, stirring is uniformly mixed it;
Solution is placed under low temperature environment by S2, makes its fast cooling, and catalyst progress amidation cross-linking reaction is then added and obtains
Hydrogel;
It is neutral that S3, which washs the gel after crosslinking to pH,.
2. requiring the preparation method according to right 1, it is characterised in that: temperature is 40~70 DEG C in step S1;Mixing time
It is 0.5~3 hour.
3. requiring the preparation method according to right 1, it is characterised in that: in step S1 acetic acid solution volume fraction be 1%~
2%, chitosan additive amount is 3wt%~4wt% of acetic acid solution.
4. requiring the preparation method according to right 1, it is characterised in that: the mass ratio of citric acid, chitosan in step S1
For 1:6~12.
5. requiring the preparation method according to right 1, it is characterised in that: the molar ratio of citric acid and dopamine is in step S1
1:0~3.
6. requiring the preparation method according to right 1, it is characterised in that: catalyst be added is 1- (3- diformazan in step S2
One of aminopropyl) -3- ethyl carbodiimide/N-N- HOSu NHS (EDC/NHS), Geniposide and glutaraldehyde.
7. preparation method according to claim 1, it is characterised in that: reaction temperature is 4 DEG C~25 DEG C in step S2.
8. preparation method according to claim 1, it is characterised in that: in step S3 wash agents useful for same be water, ethyl alcohol or
Alkaline solution.
9. a kind of hydrogel of citric acid cross-linked chitosan and dopamine, it is characterised in that: using any of claim 1~8
Item preparation method is made.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811005540.3A CN109180970B (en) | 2018-08-30 | 2018-08-30 | Citric acid crosslinked chitosan and dopamine hydrogel and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811005540.3A CN109180970B (en) | 2018-08-30 | 2018-08-30 | Citric acid crosslinked chitosan and dopamine hydrogel and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109180970A true CN109180970A (en) | 2019-01-11 |
CN109180970B CN109180970B (en) | 2020-08-04 |
Family
ID=64917057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811005540.3A Active CN109180970B (en) | 2018-08-30 | 2018-08-30 | Citric acid crosslinked chitosan and dopamine hydrogel and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109180970B (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113072716A (en) * | 2021-03-17 | 2021-07-06 | 武汉理工大学 | Preparation method of photo-crosslinked chitosan hydrogel |
CN114209889A (en) * | 2021-12-24 | 2022-03-22 | 中山大学附属第三医院(中山大学肝脏病医院) | Modified chitosan/functional short peptide composite hydrogel and preparation method and application thereof |
CN114272159A (en) * | 2022-01-12 | 2022-04-05 | 人福医药集团医疗用品有限公司 | Washing liquid based on modified chitosan micro-nano fiber particles |
CN114796597A (en) * | 2022-04-24 | 2022-07-29 | 福建师范大学 | Sphingosine-based hydrogel and preparation method and application thereof |
CN114805859A (en) * | 2022-06-16 | 2022-07-29 | 安阳师范学院 | Preparation method of heat-setting chitosan hydrogel |
CN115010958A (en) * | 2022-05-13 | 2022-09-06 | 楼天女 | Hydrogel for promoting wound healing and preparation method and application thereof |
CN115252798A (en) * | 2022-05-06 | 2022-11-01 | 南昌市第一医院 | pH sensitive hydrogel and preparation method and application thereof |
CN115753933A (en) * | 2022-12-22 | 2023-03-07 | 中国热带农业科学院南亚热带作物研究所 | Preparation method and application of carboxymethyl chitosan-based hydrogel modified electrode |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105664239A (en) * | 2016-03-23 | 2016-06-15 | 成都交大麦迪克科技有限公司 | Preparation method of self-adhesive skin repairing hydrogel |
CN106975097A (en) * | 2017-03-02 | 2017-07-25 | 四川大学 | A kind of bio-medical bonding hydrogel and preparation method thereof |
CN108341977A (en) * | 2018-03-13 | 2018-07-31 | 武汉理工大学 | A kind of citric acid cross-linked chitosan hydrogel and preparation method thereof |
-
2018
- 2018-08-30 CN CN201811005540.3A patent/CN109180970B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105664239A (en) * | 2016-03-23 | 2016-06-15 | 成都交大麦迪克科技有限公司 | Preparation method of self-adhesive skin repairing hydrogel |
CN106975097A (en) * | 2017-03-02 | 2017-07-25 | 四川大学 | A kind of bio-medical bonding hydrogel and preparation method thereof |
CN108341977A (en) * | 2018-03-13 | 2018-07-31 | 武汉理工大学 | A kind of citric acid cross-linked chitosan hydrogel and preparation method thereof |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113072716A (en) * | 2021-03-17 | 2021-07-06 | 武汉理工大学 | Preparation method of photo-crosslinked chitosan hydrogel |
CN114209889A (en) * | 2021-12-24 | 2022-03-22 | 中山大学附属第三医院(中山大学肝脏病医院) | Modified chitosan/functional short peptide composite hydrogel and preparation method and application thereof |
CN114209889B (en) * | 2021-12-24 | 2023-03-10 | 中山大学附属第三医院(中山大学肝脏病医院) | Modified chitosan/functional short peptide composite hydrogel and preparation method and application thereof |
CN114272159A (en) * | 2022-01-12 | 2022-04-05 | 人福医药集团医疗用品有限公司 | Washing liquid based on modified chitosan micro-nano fiber particles |
CN114272159B (en) * | 2022-01-12 | 2023-08-29 | 人福医药集团医疗用品有限公司 | Washing liquid based on modified chitosan micro-nano fiber particles |
CN114796597A (en) * | 2022-04-24 | 2022-07-29 | 福建师范大学 | Sphingosine-based hydrogel and preparation method and application thereof |
CN115252798A (en) * | 2022-05-06 | 2022-11-01 | 南昌市第一医院 | pH sensitive hydrogel and preparation method and application thereof |
CN115010958A (en) * | 2022-05-13 | 2022-09-06 | 楼天女 | Hydrogel for promoting wound healing and preparation method and application thereof |
CN114805859A (en) * | 2022-06-16 | 2022-07-29 | 安阳师范学院 | Preparation method of heat-setting chitosan hydrogel |
CN114805859B (en) * | 2022-06-16 | 2023-08-29 | 安阳师范学院 | Preparation method of heat-setting chitosan hydrogel |
CN115753933A (en) * | 2022-12-22 | 2023-03-07 | 中国热带农业科学院南亚热带作物研究所 | Preparation method and application of carboxymethyl chitosan-based hydrogel modified electrode |
CN115753933B (en) * | 2022-12-22 | 2023-08-11 | 中国热带农业科学院南亚热带作物研究所 | Preparation method and application of carboxymethyl chitosan-based hydrogel modified electrode |
Also Published As
Publication number | Publication date |
---|---|
CN109180970B (en) | 2020-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109180970A (en) | A kind of citric acid cross-linked chitosan and the hydrogel of dopamine and preparation method thereof | |
CN105194740B (en) | A kind of post-operation adhesion preventing hydrogel and preparation method thereof | |
Martínez-Mejía et al. | Synthesis of new chitosan-glutaraldehyde scaffolds for tissue engineering using Schiff reactions | |
CA2692553C (en) | Biocompatible rapid-gelating hydrogel and associated preparation method of spray | |
ES2237971T3 (en) | PROCEDURE FOR THE RETICULATION OF CARBOXYLED POLYSACARIDS. | |
US5496933A (en) | Super-absorbents and a process for their preparation | |
Andac et al. | Poly (hydroxyethyl methacrylate)‐based macroporous hydrogels with disulfide cross‐linker | |
CN106947020A (en) | A kind of preparation method of the chitosan-based hydrogel of high intensity | |
CN108341977A (en) | A kind of citric acid cross-linked chitosan hydrogel and preparation method thereof | |
CN107556482A (en) | A kind of injectable high intensity chitin based aquagel and its preparation method and application | |
EP0780407A2 (en) | Polyvinyl alcohol and gel therefrom | |
JPS63152667A (en) | Water-absorptive resin with high stability | |
US11498981B2 (en) | Process for producing low endotoxin chitosan | |
CN109796606A (en) | A kind of self-healing hydrogel and preparation method thereof based on MULTIPLE DYNAMIC chemical bond | |
CN107118361B (en) | Silk fibroin/carboxymethyl chitosan composite gel and preparation method thereof | |
CN111068098A (en) | Preparation method of high-strength polyvinyl alcohol hydrogel film | |
CN103554528B (en) | A kind of preparation method of the in-situ cross-linked type hydrogel of hyaluronic acid-poly aspartic acid of crosslinking agent modification | |
CN109912791A (en) | A kind of carboxylated PEG derivative, the hydrogel based on the PEG derivative and their preparation method and application | |
Potorac et al. | New hydrogels based on maleilated collagen with potential applications in tissue engineering | |
JP5156890B2 (en) | Crosslinked polymer and method for producing the same | |
CN103275351A (en) | Crosslinking agent and cross-linked polymer as well as preparation method and application thereof | |
TWI229008B (en) | Water absorbent material | |
CN109776817A (en) | A kind of photocuring selfreparing conductive hydrogel and preparation method thereof | |
CN112961264A (en) | Chitosan-gallic acid graft copolymer and preparation method and application thereof | |
CN106893018A (en) | Hydrogel and its application based on single-stranded super inner ring fluidized polymer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |